Why some US states are cracking down on private equity ownership of doctors' practices

Who actually owns a doctor's practice is an invisible fact to most patients — but over the past decade, that invisibility has become an increasingly contentious issue in US healthcare. Private equity firms built large 'practice management' chains by acquiring independent or nonprofit practices. Now that wave appears to be reversing.

According to new figures, private equity deals targeting physician practice management firms have declined sharply — by roughly 50%. That marks a striking slowdown compared with the rapid consolidation pace the industry had grown accustomed to in recent years.

There's no single cause behind the pullback, but observers point clearly to the biggest factor: a wave of states passing new laws that restrict private equity takeovers of healthcare providers or subject such deals to regulatory review.

Many of these laws lean on a long-standing legal principle known as the corporate practice of medicine doctrine, which historically aims to ensure medical decisions are made by physicians rather than profit-driven corporations. Private equity deals had often used complex management structures to work around that boundary indirectly.

Critics argue private equity ownership increases cost pressure inside practices, shortens time spent per patient, and in some cases can influence treatment decisions in ways aimed at protecting profit margins. Industry representatives counter that access to capital helps smaller, independent practices modernize technology and administrative support.

The new regulations vary from state to state. Some require advance notice and government approval for deals, while others directly prohibit certain ownership structures. The common thread is a push for greater transparency and giving regulators the authority to scrutinize transactions.

The shift is seen as part of a broader trend in US healthcare: rising public and political scrutiny of the role financial actors play in medical care. A similar wave of examination is playing out across hospital mergers and drug pricing alike.

Industry analysts say it's too early to tell whether the decline marks a temporary pause or a lasting change in direction. Some private equity firms are delaying deals while waiting for regulatory clarity, while others are shifting strategy entirely toward less-regulated segments of healthcare.

Patient advocacy groups welcome the development, but note the underlying issue goes beyond ownership structure alone — they argue the real goal should be building strong transparency and accountability mechanisms that protect care quality regardless of who owns a practice.

For now, the data is clear: ownership of doctors' practices in the US is being reshaped at a pace that would have seemed unlikely just a few years ago — and this time, the direction is running away from consolidation.